Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03310957
Brief Title: Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

First Submitted : October 11, 2017
First Submitted that Met QC Criteria : October 11, 2017
First Posted : October 16, 2017

Last Update Submitted that Met QC Criteria : September 3, 2019
Last Update Posted : September 5, 2019 (Estimate)